Pricing and welfare implications of parallel imports in the pharmaceutical industry

International Journal of Health Care Finance and Economics

Volumn 5, Issue 1, 2005, Pages 5-21

  Jelovac, Izabela ^a   Bordoy, Catalina ^b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Parallel imports; Welfare

Indexed keywords

ARTICLE; DRUG COST; DRUG INDUSTRY; ECONOMIC ASPECT; ECONOMICS; FEE; HEALTH SERVICE; HUMAN; INTERNATIONAL COOPERATION; LEGAL ASPECT; PATENT; SOCIAL WELFARE; STATISTICAL MODEL; STATISTICS;

DRUG COSTS; DRUG INDUSTRY; ECONOMIC COMPETITION; FEES, PHARMACEUTICAL; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; INTERNATIONALITY; MODELS, ECONOMETRIC; PATENTS; SOCIAL WELFARE;

EID: 14044250830     PISSN: 13896563     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10754-005-6599-x     Document Type: Article

References (14)

1. Danzon, P. M. (1998). "The Economics of Parallel Trade" PharmacoEconomics 13(3), 293-304.
2. Ganslandt, M. and K. E. Maskus. (2001). "Parallel Imports ofPharmaceutical Products in the European Union." Working paper No. 546. The research institute of industrial economics (Stockholm).
3. Hausman, J. A. and J. K. MacKie-Mason (1988). "Price Discrimination and Patent Policy." RAND Journal of Economics 19(2), 253-265.
4. Jelovac, I (2002). "On the Relationship Between the Negotiated Prices of Pharmaceuticals and the Patients' Co-Payment." Working paper 0208. Center for Economic Development. Hong Kong University of Science and Technology.
5. Jelovac, I (2004). "Monopolistic Third-Degree Price Discrimination of Subsidized Goods." Mimeo.
6. Malueg, D. A. and M. Schwartz (1994). "Parallel Imports, Demand Dispersion, and International Price Discrimination." Journal of International Economics 37, 167-195.
7. Maskus, K. E (2000). "Parallel Imports." World Economy 23(9), 1269-1284.
8. Maskus, K. E (2001). "Parallel Imports in Pharmaceuticals: Implications for Competition and Prices in Developing Countries." Final Report to the World Intellectual Property Organization.
9. Maskus, K. E. and Y. Chen (2002). "Parallel Imports in a Model of Vertical Distribution: Theory, Evidence and Policy." Pacific Economic Review 7(2), 319-334.
10. Pavcnik, N (2002). "Do Pharmaceutical Prices Respond to Potential Patient Out-of-Pocket Expenses?" RAND Journal Economics 33(3), 469-487.
11. Pecorino, P (2002). "Should the US Allow Prescription Drug Reimports from Canada?" Journal of Health Economics 796, 1-10.
12. Richardson, M (2002). "An Elementary Proposition Concerning Parallel Imports." Journal of International Economics 56, 233-245.
13. J Robinson 1933 Economics of Imperfect Competition Macmillan London
14. Schmalensee, R (1981). "Output and Welfare Implications of Monopolistic Third-Degree Price Discrimination." American Economic Review 71, 242-247.